Connecting clinical trial patients with experienced mentors that have been through the journey — improving enrollment, retention, and trust.

PatientPartner is a patient engagement platform designed to improve patient enrollment and retention for pharma study teams. The technology fosters meaningful, peer-to-peer connections between new patients (mentees) and experienced patients (mentors), offering firsthand insights into the clinical trial experience. These personalized interactions empower patients to take a proactive role in their healthcare journey, resulting in increased enrollment, stronger retention, and greater confidence in treatment decisions.

Dash Bio is a transformative Bioanalysis CRO which uses tech and automation to cut timelines from months to days while delivering unprecedented quality.

Dash Bio is a CRO on a mission to accelerate the process by which drugs are developed. Traditional bioanalysis is slow, manual and error‑prone. Dash changes the equation as the only tech-first bioanalysis partner, putting both speed and quality at the forefront. Processing every sample on an automated platform, they eliminate variability and delays, delivering high quality, GLP-compliant results for preclinical and clinical studies in days, not months. Dash provides ELISA/MSD, LC‑MS and qPCR assays across a wide range of biomatrices, sample prep methods and customization options, enabling sponsors to move from insight to action, faster. Co-founded by industry veterans who understand the pain of the traditional CRO model, Dash's model prioritizes transparency, publishing pricing upfront and backing every project with guaranteed timelines and outcomes.

Trialynx is a digital protocol authoring and study development platform that accelerates clinical trial startup through insight-driven study design and structured document authoring.

Trialynx (EZ Research Solutions Inc. dba Trialynx) is an enterprise-grade platform transforming the way clinical trials are designed, documented, and executed. Founded by leaders with decades of expertise in clinical trial operations and healthtech innovation, Trialynx enables insight-driven protocol development, structured authoring, and automation to improve compliance and reduce cycle times. The platform digitizes protocols and companion documents, supports collaboration across sponsors, CROs, and sites, and ensures scalability through secure, cloud-based infrastructure. With an active roadmap toward CDISC USDM alignment, Trialynx is shaping the future of digital clinical trial development.

Redefining the standard for evidence: Evidexa’s simulation-grade behavioral AI creates digital twins of your users, delivering credible, actionable insights to overcome adoption, engagement, and experience barriers.

Evidexa is the first simulation platform built to close the evidence gap blocking healthtech adoption. Most solutions stall when credible evidence on engagement, adherence, and real-world impact arrives too late — and at too high a cost. Evidexa is not another insights tool or persona generator. We run simulation studies with behavioral digital twins of your users, allowing you to observe and test perception, emotion, knowledge, intent, and action. These studies generate structured, simulation-grade evidence in weeks instead of months — so you can reduce risk, optimize experiences, accelerate validation, and drive adoption with confidence.

Delve Health is an AI-powered decentralized clinical trial platform built around patients—not just protocols.

We combine conversational pre-screening, adaptive engagement, and seamless wearable/device integration to reduce dropouts, boost compliance, and accelerate study timelines. Over 50,000 patients across oncology, cardiology, rare disease, and women’s health have already benefited from our platform.

OmniScience is a leading AI organization advancing clinical R&D missions through unparalleled expertise in clinical data science.  At OmniScience, we are using AI to revolutionize the way pharma manages clinical trials and employs generative AI, with the industry's first AI control tower for clinical trial operations.

—

OmniScience’s product, Vivo, is the first product to bring clinical trial management into the modern (AI) era.  It allows pharma and biotech to automate and accelerate clinical trials, enabling clinical development teams to manage and unify complex data sets from disparate sources, and provide actionable and predictive analytics. Vivo enables unprecedented levels of oversight and quality assurance with notifications, smart data management, and conversational search to better monitor and accelerate clinical trials.

—

Learn more at omniscience.bio

FindMeCure is on a mission to bring research closer to patients. Through TrialHub, our smart data platform, we combine medical and AI expertise to reshape how clinical trials are planned and run.

—

Since 2019, we’ve supported over 6,000 trials, reducing amendments and speeding up recruitment. By partnering with top CROs and pharmaceutical companies, we’re increasing the success rate of clinical trials and delivering better outcomes for all.

—

Learn more at trialhub.com

BENTO BIOLOGY PLATFORMS has created a new playbook to move the needle on clinical trial accrual, trial completion and equitable patient-finding so the drugs and therapies patients need can come to market as soon as possible.

—

BENTO transforms clinical trial participation into an immersive user experience, capable of ensuring that participation in clinical trials is accessible and inclusive, from the comfort of participants’ homes, with an engine for building trust in distrustful communities. In 2024, Bento received the Patient Empowerment Platform of the year, as well as a prestigious “Federal 100” technology award for advancing health equity.

—

Learn more at bentobio.com

Artyc is building a customizable, on-demand cold chain for healthcare and life sciences. We develop battery-powered shippers designed to address the significant challenges in transporting temperature-sensitive goods, from patient samples, to therapeutics, and reagents. Our shippers are iOT enabled providing real-time track and trace capabilities, chain of custody reporting and supply chain analytics. 

—

Artyc's initial product, the Medstow Micro, is used to support microsampling and enables a new menu of tests for DCTs and direct-to-patient shipping. Artyc's second product, the Medstow 4L supports intra-lab shipments, direct-to-cite shipments, as well as commercial shipments, and is launching in late 2024.

—

Learn more at shipartyc.com

Geno.Me is a biotechnology company that was born from the idea of empowering people to take greater ownership of their health data, because it is a valuable and necessary asset to advance medical research. With a focus on creating better ways to treat populations that have diseases with a genetic predisposition, the organization allows people to democratize their health data in a safe, secure and meaningful way.

—

Learn more at yourgeno.me

Operational AI for the Clinical Research Industry

—

Kenosha AI is transforming clinical research operations with enterprise-grade AI to accelerate clinical trial timelines, enhance decision making ability, and ultimately speed access to life-saving treatments.  By integrating advanced AI-powered tools like copilots and GPTs into workflows, we are streamlining some of the most time-consuming, repetitive, and resource-intensive aspects of clinical research operations.

—

Learn more at Kenosha.ai

Learn more about RegChat.com | AI-powered Clinical Regulatory Guidance Assistant